Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
The Irish Lung Fibrosis Association (ILFA) and ELF were recently asked by Prof. Athol Wells to contribute to an editorial to accompany a paper in the Journal of Respirology. Prof. Wells, ILFA and ELF had previously collaborated on work focussing on communication difficulties between healthcare professionals and people living with idiopathic pulmonary fibrosis (IPF): https://openres.ersjournals.com/content/5/2/00055-2019.figures-only.
The current paper explains how the Australian Lung Foundation has provided virtual peer support, to people living with IPF who lived a long way away from each other.
This paper being published during the COVID-19 pandemic, meant it was an important time to discuss some of the issues related to telemedicine for future healthcare provision, including points such as:
Read the full paper:
Title: Patients with idiopathic pulmonary fibrosis: Overcoming ‘geographic isolation’
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79